What is the optimal treatment for early Parkinson’s disease?

Abstract

Get full access to this article

View all access options for this article.

References

1 Lees

on behalf of the Parkinson’s Disease Research Group of the United

ingdom. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson’s disease. BMJ 1995; 311:1602–7.

Weiner

Reich

SG.

Agonist or levodopa for Parkinson disease? Ultimately, it doesn’t matter; neither is good enough. Neurology 2008; 71:470–1.

Clarke

Deane

KHO.

Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson’s Disease. Cochrane Database of Systematic Reviews 2001, Issue 1.